A Phase Ic/IIb Study to Evaluate the Efficacy，Safety and Pharmacokinetics of HST in Patients With CHB

NCT06122454 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Efficacy
Safety
Pharmacokinetics

Interventions

DRUG: Hepenofovir Fumarate Tablets

Sponsor

Xi'an Xintong Pharmaceutical Research Co.,Ltd.

Collaborators

[object Object]